Manuela Lo Porto

Manuela Lo Porto is currently a Principal CRA at Medpace, with extensive experience as a Clinical Research Associate in various fields such as Oncology, Hemophilia, Respiratory, and Metabolic diseases. Manuela has a strong background in clinical research, with a Master's Degree in Biology and Biomedical Applications. Prior to their current role, Manuela has worked at companies like Bayer and AstraZeneca Italia, gaining valuable experience in Phase I, II, and III Clinical Studies. Additionally, Manuela has conducted research in areas such as immune reconstitution in patients with hematopoietic malignant disorders and chemoresistance in leukemia patients.